Columbia, Maryland, Nov. 18, 2011 (GLOBE NEWSWIRE) -- Columbia, MD - JPB Partners, LLC has announced that it provided strategic advisory services to Bioscan, Inc., of Washington, DC, in the sale of its radiopharmaceutical equipment operating division to Eckert & Ziegler of Berlin, Germany earlier this year. Terms of the transaction were not disclosed. "When Bioscan made the decision to focus on its fast-growing molecular imaging business, we sought a partner that would enable us to find a strategic home for the radiopharmaceutical equipment business line and the thousands of customers that use Bioscan radioanalytic and radiochemistry instruments every day," stated Alex Kleinman, Vice President of Marketing and Business Development for Bioscan. "We are delighted that we selected JPB Partners to be that firm. JPB Partners brought industry knowledge from related transactions, coordinated the due diligence process, supported interactions and negotiations with Eckert & Ziegler, and managed the process in a first class, professional manner. With the help of JPB Partners, we not only received appropriate value for the business line, but also met our objections of finding a strategic home for our radiopharmaceutical equipment business with Ecker & Ziegler."
